Endo International plc announced that it received U.S. Food and Drug Administration (FDA) approval of Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In